Healthcare -
Biotechnology - NASDAQ - US
$ 9.61
-17.1 %
$ 482 M
Market Cap
-3.28
P/E
RGNX - OPERATING INCOME
Operating Income RGNX - REGENXBIO Inc.
-233 M
LAST VALUE
5.78%
2 YEAR CAGR
-9.39%
5 YEAR CAGR
-51.42%
10 YEAR CAGR